BarrettKatzMDMBA
Ophthalmology • Cutchogue, NYNeuro-Ophthalmology
Emeritus Professor, Ophthalmology, Neurology and Neurosurgery, Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY
Dr. Katz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 Strohson Rd
Cutchogue, NY 11935Phone+1 646-831-3799- Is this information wrong?
Education & Training
University of California San Francisco School of MedicinePost-Doctoral Fellowship, Fellowship in Neuro-Ophthalmology, 1981 - 1982- University of California (San Francisco)Fellowship, Neuro-Ophthalmology, 1980 - 1981
Tufts Medical CenterResidency, Ophthalmology, 1978 - 1981
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1975 - 1978
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1975 - 1978
Clinical Center at the National Institutes of HealthFellowship, Neuro-Virology, 1974 - 1975
University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1973 - 1974
Case Western Reserve University School of MedicineClass of 1973
Certifications & Licensure
CA State Medical License 1984 - Present
AZ State Medical License 1981 - Present
NY State Medical License 1974 - 2025
DC State Medical License 1999 - 2004- American Board of Ophthalmology Ophthalmology
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Fellow American Academy of Neurology
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure Start of enrollment: 2007 Oct 01
- Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa Start of enrollment: 2018 Sep 26
- RESCUE and REVERSE Long-term Follow-up Start of enrollment: 2018 Jan 09
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsGene Therapies for the Treatment of Leber Hereditary Optic Neuropathy.José-Alain Sahel, Nancy J. Newman, Patrick Yu-Wai-Man, Catherine Vignal-Clermont, Valerio Carelli, Valérie Biousse, Mark L. Moster, Robert C. Sergott, Thomas Klopstock...> ;International Ophthalmology Clinics. 2021 Oct 1
- 4 citationsCross-Sectional Analysis of Baseline Visual Parameters in Subjects Recruited Into the RESCUE and REVERSE ND4-LHON Gene Therapy Studies.Mark L. Moster, Robert C. Sergott, N. J. Newman, Patrick Yu-Wai-Man, V. Carelli, Molly Scannell Bryan, Gerard Smits, Valérie Biousse, Catherine Vignal-Clermont, Thomas...> ;Journal of Neuro-Ophthalmology. 2021 Sep 1
- 72 citationsEfficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease OnsetNancy J. Newman, Patrick Yu-Wai-Man, Valerio Carelli, Mark L. Moster, Valérie Biousse, Catherine Vignal-Clermont, Robert C. Sergott, Thomas Klopstock, Alfredo A. Sadun...> ;Ophthalmology. 2021 Jan 12
- Join now to see all
Press Mentions
Chutes & Ladders—GSK Vaccine Exec Reichman Splits to Take Biotech CEO PostJanuary 22nd, 2021- miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership TeamJanuary 19th, 2021
GenSight Biologics Appoints Magali Taiel as Chief Medical OfficerOctober 8th, 2019- Join now to see all
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
